4//SEC Filing
Harrison Seth Loring 4
Accession 0000899243-22-037475
CIK 0001744659other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 5:48 PM ET
Size
10.8 KB
Accession
0000899243-22-037475
Insider Transaction Report
Form 4
Harrison Seth Loring
Director
Transactions
- Sale
Common Stock
2022-11-30$47.60/sh−5,179$246,543→ 148,063 total(indirect: See Footnote) - Sale
Common Stock
2022-11-30$47.60/sh−4,779$227,501→ 136,301 total - Sale
Common Stock
2022-11-30$46.44/sh−6,851$318,130→ 153,242 total(indirect: See Footnote) - Sale
Common Stock
2022-11-30$46.44/sh−6,322$293,565→ 141,080 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.28 to $47.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $47.29 to $47.93, inclusive.
- [F3]Represents shares held directly by Les Pommes, LLC, a family limited liability company for which the reporting person is the manager. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001404955
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 5:48 PM ET
- Size
- 10.8 KB